CoChat

CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes

Słomiński, Bartosz, Ławrynowicz, Urszula, Ryba-Stanisławowska, Monika, Skrzypkowska, Maria, Myśliwska, Jolanta, Myśliwiec, Małgorzata · 2019 · Cytokine
Cited by 14

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aim: In the currently available literature there are no works investigating the correlation between CCR5‐&Dgr;32 polymorphism and dyslipidemia in children with type 1 diabetes mellitus (T1D). Therefore, we have decided to explore the potential role played by this polymorphic locus in the incidence of dyslipidemia as an important risk factor for cardiovascular disease (CVD) in patients with T1D. Methods: A total of 380 patients with T1D were selected. Patients were divided into two groups: 180 patients with diabetic dyslipidemia and 200 controls without dyslipidemia. Characterization of CCR5‐&Dgr;32 genotypes was analyzed by polymerase chain reaction. Logistic regression model was used to examine the association between CCR5‐&Dgr;32 polymorphism and dyslipidemia. Results: When participants were analyzed according to CCR5‐&Dgr;32 polymorphism, &Dgr;32 carriers presented higher levels of: HbA1c (p < 0.001), fasting plasma glucose (p < 0.001), LDL (p = 0.02) as well as TG (p = 0.01) and lower levels of HDL (p = 0.01) than noncarriers. Moreover, the minor allele &Dgr;32 was more frequent in dyslipidemic subjects than controls (p < 0.001) and conferred an increased individual risk for dyslipidemia (OR = 2.327; 95% CI = 11.241–4.365; p = 0.009). Conclusions: The findings of our study suggest that the CCR5‐&Dgr;32 polymorphism is associated with elevated plasma lipid levels and the &Dgr;32 allele increases the risk of dyslipidemia in patients with T1D. Identification of the functional variant underlying these associations may potentially lead to the development of a novel and adjunctive approach for the treatment of dyslipidemia and CVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cyto.2018.11.005

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 14

Metadata

Authors
Słomiński, B., Ławrynowicz, U., Ryba-Stanisławowska, M., Skrzypkowska, M., Myśliwska, J., & Myśliwiec, M.
Venue
Cytokine
Publisher
Elsevier BV
Published
2019-02
Volume
114
Pages
81-85
ISSN
1043-4666 (ISSN-L)
OpenAlex
W2900352728
Cited by
14
References
4
FWCI
0.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes. https://app.cochat.ai/papers/10.1016/j.cyto.2018.11.005
The paper
Słomiński, B., Ławrynowicz, U., Ryba-Stanisławowska, M., Skrzypkowska, M., Myśliwska, J., & Myśliwiec, M. (2019). CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes. Cytokine. https://doi.org/10.1016/j.cyto.2018.11.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.